Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share (VVOS)

Historical Holders from Q4 2023 to Q3 2025

Symbol
VVOS on Nasdaq
Type / Class
Equity / Common stock, par value $0.0001 per share
Shares outstanding
6,713,803
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
686,727
Holdings value
$2,129,135
% of all portfolios
0%
Number of holders
22
Number of buys
11
Number of sells
-8
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share (VVOS)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
V-CO Investors LLC 19.9% +100% $4,188,594 +$2,583,360 1,342,498 +161% SP Manager LLC 09 Jun 2025
LUO DAWEI 8.52% $3,432,096 572,016 Dawei Luo 08 Jul 2025
INTRACOASTAL CAPITAL, LLC 4.99% $796,804 297,315 Mitchell P. Kopin 22 Dec 2024

Institutional Holders of Vivos Therapeutics, Inc. - Common stock, par value $0.0001 per share (VVOS)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 686,727 $2,129,135 +$875,070 $3.1 22
2025 Q2 402,082 $1,271,158 +$424,559 $3.16 18
2025 Q1 281,633 $802,423 -$1,021,557 $2.85 19
2024 Q4 466,818 $2,003,111 +$1,082,494 $4.29 19
2024 Q3 245,048 $630,697 +$156,010 $2.61 22
2024 Q2 186,896 $433,846 -$444,091 $2.22 18
2024 Q1 133,960 $646,578 -$323,172 $4.83 13
2023 Q4 250,612 $3,117,234 +$3,117,234 $12.44 14